Funding for this research was provided by:
National Institutes of Health (UL1 TR0001414, T32CA009054)
Received: 2 November 2019
Accepted: 24 December 2019
First Online: 2 January 2020
Ethics approval and consent to participate
: All primary human samples used in this study were derived from participants who consented to an IRB approved study “Role of Inflammation in Myeloproliferative Neoplasm” at University of California, Irvine. All animal use in this protocol was in accordance with an approved IACUC protocol.
: All authors have reviewed the manuscript and consent for publication.
: The authors declare that they have no competing interests.